Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite results in increased expression of RASEF mRNA | increases expression | 18687144
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of RASEF mRNA | decreases expression | 19150397
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of RASEF mRNA | increases expression | 20382639
|
D004958 |
Estradiol |
Estradiol results in decreased expression of RASEF mRNA | decreases expression | 19429434
|
D020849 |
Raloxifene |
Raloxifene results in decreased expression of RASEF mRNA | decreases expression | 19429434
|
D013629 |
Tamoxifen |
Tamoxifen results in decreased expression of RASEF mRNA | decreases expression | 19429434
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
5.16 | 14745880 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.16 | 11473722 |
MESH:D000419 |
Albuminuria |
|
Raloxifene |
5.04 | 17308373 17451421 |
MESH:D000544 |
Alzheimer Disease |
|
Raloxifene |
2.60 | 15800139 |
MESH:D001930 |
Brain Injuries |
|
Raloxifene |
4.96 | 16580743 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
1.94 | 17289903 16675129 17018787 17261762 18497071 14630087 12948864 19861407 |
MESH:D001943 |
Breast Neoplasms |
|
Raloxifene |
1.94 | 16837676 15572757 17242785 17952589 17049068 16912660 17595753 17261762 17440819 15758505 15775269 17893378 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.94 | 18629630 18815881 19155303 19115204 20065188 21138602 18984771 19288272 19289846 16273361 16202921 21152245 11161223 20859285 20135344 19189212 19066611 19200415 18821012 19410462 18855134 17893378 19142967 19103187 15668708 16873071 20005174 20390343 16818667 19189210 18351453 17242785 18997820 19059307 15565566 19084267 20544844 17261762 18425577 17440819 19011961 19487384 19244106 17049068 19221464 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
5.00 | 16111702 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.99 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.11 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
3.11 | 16924424 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Raloxifene |
10.68 | 17572228 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
10.68 | 17572228 |
MESH:D002318 |
Cardiovascular Diseases |
|
Raloxifene |
3.68 | 15775269 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.44 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
7.44 | 18566989 |
MESH:D003072 |
Cognition Disorders |
|
Raloxifene |
5.10 | 15800139 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.85 | 19031437 |
MESH:D003865 |
Depressive Disorder, Major |
|
Raloxifene |
4.49 | 17474826 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
16.98 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
Raloxifene |
16.98 | 17308373 15920148 17451421 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
16.98 | 19279558 |
MESH:D004487 |
Edema |
|
Raloxifene |
3.70 | 15860553 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Raloxifene |
10.75 | 15845917 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
10.75 | 19031437 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
8.12 | 19148513 11473722 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
8.12 | 20544844 19155303 16202921 17893378 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
2.14 | 20426865 |
MESH:D005234 |
Fatty Liver |
|
Raloxifene |
9.25 | 17473493 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
9.25 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.43 | 16709447 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
5.07 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.72 | 19069698 |
MESH:D006331 |
Heart Diseases |
|
Raloxifene |
3.77 | 11110106 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.64 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.36 | 17088409 |
MESH:D006973 |
Hypertension |
|
Raloxifene |
2.97 | 17577099 15787275 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
2.51 | 19457130 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
3.18 | 16627594 16393666 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.76 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
8.42 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
8.42 | 18625569 |
MESH:D007889 |
Leiomyoma |
|
Raloxifene |
4.90 | 16973256 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.40 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
2.53 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
2.53 | 18564211 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
2.32 | 16684651 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.50 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
1.74 | 18625569 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.30 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.69 | 16891317 11807958 17203775 11408345 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
6.69 | 16827153 19196722 19196723 14580682 11731420 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
14.78 | 19453300 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
14.78 | 19453300 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
1.92 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.72 | 15990972 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.30 | 16166281 16966607 18303189 |
MESH:D018200 |
Mixed Tumor, Mullerian |
|
Raloxifene |
6.17 | 15863610 |
MESH:D009101 |
Multiple Myeloma |
|
Raloxifene |
3.68 | 16497877 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.55 | 16810080 |
MESH:D009232 |
Myxoma |
|
Raloxifene |
6.17 | 16343187 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.66 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.60 | 19410462 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.61 | 19189210 19200415 19196722 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.27 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
4.09 | 11399458 16427766 |
MESH:D010024 |
Osteoporosis |
|
Raloxifene |
3.59 | 17882678 19059307 15775268 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Raloxifene |
4.63 | 17893378 15579764 15758505 17823083 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
2.30 | 19401270 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
5.38 | 10923243 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.26 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
2.53 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Raloxifene |
2.53 | 15731164 16536755 16220300 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
2.53 | 15067354 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.14 | 17975199 17365031 15814490 17322281 |
MESH:D011693 |
Purpura |
|
Raloxifene |
6.17 | 15770314 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
4.90 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.58 | 19457130 |
MESH:D020521 |
Stroke |
|
Raloxifene |
4.11 | 16837676 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
15.84 | 19048282 |
MESH:D013978 |
Tibial Fractures |
|
Raloxifene |
15.84 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Raloxifene |
5.61 | 17572228 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
5.61 | 17572228 8653321 16712894 |
MESH:D054556 |
Venous Thromboembolism |
|
Raloxifene |
5.82 | 16837676 |
MESH:D014846 |
Vulvar Neoplasms |
|
Raloxifene |
6.17 | 16343187 |